EMA Gives Approval to Several Cancer Treatments
Approvals were recommended for treatments of ovarian cancer, lung cancer, bleeding disorders, respiratory disease, and more. On Sept. 20, 2024, the European Medicines Agency (EMA) announced that its Committee for Human Medicinal Products (CHMP) has …